Longitudinal direct medical costs associated with constipation in women
- PMID: 21091523
- PMCID: PMC3242366
- DOI: 10.1111/j.1365-2036.2010.04513.x
Longitudinal direct medical costs associated with constipation in women
Abstract
Background: Although direct medical costs for constipation-related medical visits are thought to be high, to date, there have been no studies examining longitudinal resource utilisation in adults with constipation.
Aim: To estimate the incremental direct medical costs associated with constipation in women.
Methods: This is a nested case-control study. The study population consisted of all mothers of 5718 children in the population-based birth cohort born during 1976-1982 in a community. The cases presented to the medical facilities with constipation. The controls were randomly selected and matched to cases in a 2:1 ratio. Direct medical costs for constipated women and controls were collected for the years 1987-2002.
Results: We identified 168 women with a diagnosis of constipation. The total direct medical costs over the 15-year period for constipated subjects were more than double those of controls [$63 591 (95% CI: 49 786-81 396) vs. $24 529 (95% CI: 20 667-29 260)]. The overall out-patient costs for constipated women were $38 897 (95% CI: 31 381-48 253) compared to $15 110 (95% CI: 12 904-17 781) for controls. The median of annual out-patient visits for constipated women was 0.16 compared to 0.11 for controls.
Conclusion: Women with constipation have significantly higher medical care utilisation and expenditures compared with women without constipation.
© 2010 Blackwell Publishing Ltd.
Conflict of interest statement
Disclosures: No conflict of interest to disclose for all authors.
Figures
Similar articles
-
Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):47-54. doi: 10.1097/MPG.0b013e3181e67058. J Pediatr Gastroenterol Nutr. 2011. PMID: 20890220 Free PMC article.
-
Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.J Manag Care Spec Pharm. 2014 Apr;20(4):382-90. doi: 10.18553/jmcp.2014.20.4.382. J Manag Care Spec Pharm. 2014. PMID: 24684643 Free PMC article.
-
A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort.J Med Econ. 2017 Mar;20(3):273-279. doi: 10.1080/13696998.2016.1253584. Epub 2016 Nov 10. J Med Econ. 2017. PMID: 27783533 Free PMC article.
-
The health-related quality of life and economic burden of constipation.Pharmacoeconomics. 2005;23(5):461-76. doi: 10.2165/00019053-200523050-00006. Pharmacoeconomics. 2005. PMID: 15896098 Review.
-
Economic aspects of pharmacotherapy for chronic constipation.Pharmacoeconomics. 1995 Jan;7(1):14-24. doi: 10.2165/00019053-199507010-00003. Pharmacoeconomics. 1995. PMID: 10155290 Review.
Cited by
-
Laxative effect of Wenyang Yiqi Decoction on loperamide-induced astriction model mice.Ann Transl Med. 2023 Feb 28;11(4):170. doi: 10.21037/atm-23-6. Ann Transl Med. 2023. PMID: 36923099 Free PMC article.
-
Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome.Gastroenterol Hepatol (N Y). 2012 Oct;8(10):653-60. Gastroenterol Hepatol (N Y). 2012. PMID: 24683372 Free PMC article.
-
Yield and cost of performing screening tests for constipation in children.Can J Gastroenterol. 2013 Dec;27(12):e35-8. doi: 10.1155/2013/945165. Epub 2013 Nov 13. Can J Gastroenterol. 2013. PMID: 24228262 Free PMC article.
-
Recent advances in the management of difficult constipation.Curr Gastroenterol Rep. 2012 Aug;14(4):306-12. doi: 10.1007/s11894-012-0269-1. Curr Gastroenterol Rep. 2012. PMID: 22661291 Review.
-
Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.Br J Nutr. 2015 Nov 28;114(10):1638-46. doi: 10.1017/S0007114515003347. Epub 2015 Sep 18. Br J Nutr. 2015. PMID: 26382580 Free PMC article. Clinical Trial.
References
-
- Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96:3130–7. - PubMed
-
- Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ., 3rd Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993;105:781–90. - PubMed
-
- Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–80. - PubMed
-
- Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E, Lipton RB, Farup CE. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol. 1999;94:3530–40. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical